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Abstract
The aim of perioperative haemodilution is to reduce loss of red
blood cells during elective surgery. The oncotic and molecular
characteristics of the various plasma substitutes employed deter-
mine how effectively normovolaemia is maintained, and their non-
oncotic effects include alterations in microvascular perfusion. In the
previous issue of Critical Care, Martini and colleagues assessed
the effects of haemodilution with either polyethylene glycol
(PEG)ylated albumin or a commercially available hydroxyethyl
starch-based colloid in a hamster haemorrhage model. PEGylated
albumin was superior to hydroxyethyl starch, as reflected by
survival, haemodynamic parameters and assessment of the
microcirculation using intravital microscopy.
In the previous issue of Critical Care, Martini and colleagues
[1] assessed the effects of haemodilution with either poly-
ethylene glycol (PEG)ylated albumin or a commercially avail-
able hydroxyethyl starch-based colloid in a hamster haemor-
rhage model. The aim of perioperative haemodilution, also
termed acute normovolaemic hemodilution (ANH), is to reduce
loss of red blood cells during elective surgery. It involves the
collection of several units of blood from the patient before the
operation and substitution of an equivalent volume of plasma
expander. Although surgical blood loss remains unchanged,
the lost blood contains relatively fewer red blood cells and
clotting factors. The patient’s blood is returned to them once
haemostasis is achieved. Some regard ANH to be an
underused technique that can significantly reduce exposure
to allogeneic blood [2]. The oncotic and molecular properties
of the various plasma substitutes employed in ANH determine
how effectively normovolaemia is maintained. Fluid resusci-
tation using colloids typically requires one-quarter to one-half
the infusion volume of crystalloids [3]. Whether the advan-
tages of colloid use in elective surgery apply equally to the
critically ill, and in all such populations, is less certain. Thus,
on the basis of a prospectively defined subset of trauma
patients in one large-scale clinical trial of albumin versus
crystalloid resuscitation [4], the former was associated with
an increased risk for death. By contrast, in post hoc analysis,
patients with sepsis might have benefited from albumin.
The microcirculation is the primary site for gas and nutrient
exchange. Perturbations in capillary perfusion may have more
adverse prognostic significance [5] than traditional markers
of oxygen utilization, and are implicated in the pathogenesis
of organ failure in human sepsis [6]. The physicochemical
attributes of the colloids determine their nononcotic effects,
which include alterations in microvascular perfusion and
integrity, and modulation of inflammation and coagulation.
Martini and colleagues [1] explored these effects further by
examining the consequences of slow replacement of 50% of
the circulating volume in hamsters with either PEGylated
albumin or a commercially available hydroxyethyl starch (HES)-
based colloid, namely Voluven® (Fresenius Kabi, Austria),
followed by removal of 60% of circulating volume over 1 hour.
Blood was removed in an exponential manner in order to
simulate surgical haemorrhage, and the surviving animals
were observed using intravital microscopy in their shocked
state for a further hour.
Animals receiving PEG-albumin all survived the experiment. By
contrast, none of the HES animals completed the 1-hour
hemorrhage stage. Other end-points also favoured PEG-
albumin, in that for the first 30 minutes of experimental
haemorrhage mean arterial blood pressure and heart rate were
better supported than with HES. Moreover, from baseline the
PEG-albumin group had a lower haematocrit, implying that
more of the study solution remained within the vascular
compartment. Furthermore, significantly more arteriolar and
venular constriction was detectable during haemorrhage in the
HES group. More convincingly, the arteriolar and venular flow
had already begun to diminish after haemodilution and fell
further during haemorrhage. Finally, these changes were
mirrored by the reduction in functional capillary density, which
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decreased in both groups during haemorrhage, but more so
when HES was administered.
How robust are these data? The group concerned has a
wealth of experience in employing these techniques.
Additionally, although performed in animals, clinically relevant
end-points were used. However, the study does have some
limitations. First, only five animals were studied in each group.
Second, blood loss was excessive and allowed only limited
data for the HES group to be provided; a less severe protocol
might have been more revealing. Third, the microcirculatory
bed studied sits within the superficial connective tissue; the
changes observed may not reflect changes in more clinically
relevant organs, such as the viscera. Fourth, although the
data indicate beneficial effects of PEG-albumin as a colloid,
they may not pertain equally to the perioperative situation, in
which the extent of haemodilution and severity of the blood
loss are less. Finally, the authors rightly draw attention to the
effects of the suspending fluid. It could be argued that the
excess chloride load administered in the HES group might
have contributed to their trend toward acidosis that occurred
before onset of haemorrhage.
Where does this work lead us? In models of extreme haemor-
rhage, microvascular perfusion appears to be better main-
tained if plasma expanders of greater viscosity are employed.
Viscous drag is thought to stimulate local nitric oxide
production and vasodilatation. Despite not being a highly
viscous solution, PEG-albumin has been shown to sustain
microvascular perfusion. Although this may be a result of
direct physical interaction of the PEG with the endothelium,
its potential role as a nitric oxide distributor deserves further
investigation. Use of techniques applicable to humans, such
as orthogonal polarization spectral imaging, sidestream dark
field imaging, or near-infrared spectroscopy, has been
reported in this hamster skinfold model [7] but not under
conditions of extreme haemorrhage. Confirmation of the
equivalence of these methods in haemorrhage or sepsis
would be valuable before moving on to the clinical arena.
PEG-albumin holds promise as the next generation of ‘super-
colloids’ emerge, both as an effective plasma volume expan-
der and potentially as an ameliorator of microvascular dys-
function. Watch this space!
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